Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Zealand Pharma A/S (ZLDPF : OTC)

• Company Description    Zealand Pharma A/S is a biotechnology company. It focused on the discovery, design and development of peptide-based medicines. The company's pipeline includes ZP4207, single-dose rescue treatment for acute, severe hypoglycemia; ZP1848 for short bowel syndrome and ZP4207, multiple-dose version intended for use in a dual-hormone artificial pancreas system for better hypoglycemia control and diabetes management and other earlier-stage clinical and preclinical peptide therapeutics are in clinical stage. Zealand Pharma A/S is based in Copenhagen, Denmark. Number of Employees: 481

• Price / Volume Information    Yesterday's Closing Price: $45.02 Daily Weekly Monthly 20 Day Moving Average: 330 shares Shares Outstanding: 71.53 (millions) Market Capitalization: $3,220.08 (millions) Beta: 0.88 52 Week High: $83.12 52 Week Low: $35.93 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 4.97% 4.15% 12 Week -4.96% -7.29% Year To Date -37.12% -41.93%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Sydmarken 11 Soborg - Copenhagen,G7 2860 DNK ph: 45-8877-3600 fax: 45-8877-3898 investors@zealandpharma.com http://www.zealandpharma.com

• General Corporate Information    Officers Adam Steensberg - Chief Executive Officer and President Martin Nicklasson - Chairman of the Board of Directors Ivan Moller - Executive Vice President;Chief Operating Officer Henriette Wennicke - Executive Vice President and Chief Financial Offic Bernadette Connaughton - Director Peer Information Zealand Pharma A/S (CORR.) Zealand Pharma A/S (RSPI) Zealand Pharma A/S (CGXP) Zealand Pharma A/S (BGEN) Zealand Pharma A/S (GTBP) Zealand Pharma A/S (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: K9898X127 SIC: 8880 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 71.53 Most Recent Split Date: (:1) Beta: 0.88 Market Capitalization: $3,220.08 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-1.62 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $2.37 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: 19.02 Trailing 12 Months: 3.34 PEG Ratio: - Price Ratios Price/Book: 1.42 Price/Cash Flow: 3.26 Price / Sales: 2.29 EPS Growth vs. Year Ago Period: -29.85% vs. Previous Quarter: -7.41% Sales Growth vs. Year Ago Period: 366.78% vs. Previous Quarter: -50.42% ROE 06/30/26 - - 03/31/26 - 41.80 12/31/25 - 48.10 ROA 06/30/26 - - 03/31/26 - 38.49 12/31/25 - 43.91 Current Ratio 06/30/26 - - 03/31/26 - 37.17 12/31/25 - 23.57 Quick Ratio 06/30/26 - - 03/31/26 - 37.17 12/31/25 - 23.57 Operating Margin 06/30/26 - - 03/31/26 - 68.82 12/31/25 - 70.06 Net Margin 06/30/26 - - 03/31/26 - 68.82 12/31/25 - 70.06 Pre-Tax Margin 06/30/26 - - 03/31/26 - 74.39 12/31/25 - 75.98 Book Value 06/30/26 - - 03/31/26 - 31.68 12/31/25 - 31.61 Inventory Turnover 06/30/26 - - 03/31/26 - 0.17 12/31/25 - 0.16 Debt-to-Equity 06/30/26 - - 03/31/26 - 0.02 12/31/25 - 0.02 Debt-to-Capital 06/30/26 - - 03/31/26 - 2.08 12/31/25 - 2.00

Powered by Zacks Investment Research ©